Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Venetoclax Combined with Daunorubicin and Cytarabine (2 + 6) in Acute Myeloid Leukemia: Updated Results of a Phase II Trial

Blood (2023) 142 (Supplement 1): 969.

https://doi.org/10.1182/blood-2023-179205

Published: 2023

Journal Articles

A Prognostic Nomogram Survival Model for Newly Diagnosed Patients with AIDS-Related Diffuse Large B-Cell Lymphoma: A Multicenter Cohort Study in China

Tao Yang, Yang Liang, Chaoyu Wang, Jun Liu, Yan Wu, Haiyan Min, Yunhong Huang, Guo Wei, Wei Zhang, Min Wang, Xiaoqiong Tang, Zailin Yang, Li Jun, Hui Zhou, Yao Liu

Blood (2023) 142 (Supplement 1): 4480.

https://doi.org/10.1182/blood-2023-179132

Published: 2023

Journal Articles

Treatment Pattern and Survival of Human Immunodeficiency Virus Infection-Related Lymphoma in China 2008-2021

Jun Liu, Chaoyu Wang, Tao Yang, Yan Wu, Haiyan Min, Yunhong Huang, Guo Wei, Wei Zhang, Min Wang, Xiaoqiong Tang, Hui Zhou, Yao Liu

Blood (2023) 142 (Supplement 1): 6299.

https://doi.org/10.1182/blood-2023-182535

Published: 2023

Journal Articles

Clinical Analysis of 22 Cases of HIV-Associated Hodgkin Lymphoma in China

Chaoyu Wang, Jun Liu, Yan Wu, Haiyan Min, Tao Yang, Wei Zhang, Hui Zhou, Yao Liu

Blood (2023) 142 (Supplement 1): 6293.

https://doi.org/10.1182/blood-2023-180572

Published: 2023

Journal Articles

First-in-Human Clinical Study of a Novel CD7-Targeted Chimeric Antigen Receptor (CAR)-T Cell Therapy for Refractory/Relapsed Mixed Phenotype Acute Leukemia (MPAL)

Xian Zhang, Junfang Yang, Jingjing Li, Yanze Shi, Yunchao Su, Ying Liu, Min Ba, Yan Wu, Wenqian Li, Jianqiang Li, Peihua Lu

Blood (2021) 138 (Supplement 1): 1741.

https://doi.org/10.1182/blood-2021-146425

Published: 2021

Journal Articles

Successful 24-Hours Manufacture of Anti-CD19/CD22 Dual Chimeric Antigen Receptor (CAR) T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Junfang Yang, Pengfei Jiang, Xian Zhang, MD, Jingjing Li, Yan Wu, Li Xu, Yunchao Su, Xiaona Hu, Xiaoyan Zhao, Qi Dong, Songbai Cai, Zhenguang Wang, Yuezhang Chen, Xun Ye, Jiaping He, Nanjing Lin, Wei Cao, Martina Sersch, MD PhD, Peihua Lu, MD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-136866

Published: 2020

Journal Articles

Mitochondrial carrier homolog 2 is necessary for AML survival

Blood (2020) 136 (1): 81–92.

https://doi.org/10.1182/blood.2019000106

Published: 2020

Includes: Supplemental data

Journal Articles

Mitochondrial Carrier Homolog 2 (MTCH2) Regulates the Differentiation of AML Cells By Controlling Pyruvate Entry into the Mitochondria, Nuclear Localization of Pyruvate Dehydrogenase Complex and H3 and H4 Histone Acetylation

Dilshad H. Khan, Michael Mullokandov, Yan Wu, Marcela Gronda, MSc, Rose Hurren, BSc, Xiaoming Wang, Neil MacLean, Danny V. Jeyaraju, PhD, G. Wei Xu, Rob C. Laister, PhD, Zachary Blatman, Troy Ketela, Mark D. Minden, MD PhD, Atan Gross, PhD, Aaron D. Schimmer, MDPhD

Blood (2017) 130 (Supplement 1): 299.

https://doi.org/10.1182/blood.V130.Suppl_1.299.299

Published: 2017

Journal Articles

The Mitochondrial Carrier Homolog 2 (MTCH2) Regulates the Differentiation of AML Cells By Influencing the Localization of Pyruvate Dehydrogenase Complex and H3 and H4 Histone Acetylation

Dilshad H. Khan, PhD, Michael Mullokandov, Yan Wu, Marcela Gronda, Rose Hurren, Xiaoming Wang, Neil MacLean, Rob C. Laister, PhD, Atan Gross, Aaron D. Schimmer, MD PhD

Blood (2016) 128 (22): 1562.

https://doi.org/10.1182/blood.V128.22.1562.1562

Published: 2016

Journal Articles

High Transcription Levels Of S100A8 and S100A9 In Acute Myeloid Leukemia Are Predictors For Poor Overall Survival

Shao-yan Hu, MD, PhD, Ming-ying Zhang, Shui-yan Wu, Dong Wu, Neetika Ashwani, Jian Pan, Ph.D., Hai-long He, Jian-nong Cen, MD, Zi-Xing Chen, MD, Chien-Shing Chen, MD, PhD

Blood (2013) 122 (21): 2610.

https://doi.org/10.1182/blood.V122.21.2610.2610

Published: 2013

Journal Articles

IGFBP7 Gene Promoting Cell Proliferation in Acute Myeloid Leukemia Through Activation of AKT3 and CCND1

Shaoyan Hu, MD, PhD, Shui-yan Wu, MD, Jian-nong Cen, MD, Jian Pan, Ph.D., Xiaofei Qi, Ph.D., Zixing Chen, MD, Ph.D., Xing Feng, MD, Ph.D., Chien-Shing Chen, MD, PhD

Blood (2012) 120 (21): 1447.

https://doi.org/10.1182/blood.V120.21.1447.1447

Published: 2012

Journal Articles

C3aR1 Contributed to Acute Myeloid Leukemia Acquired Resistance to ABT-737 and Involved In the Process of AML

Shaoyan Hu, MD, PhD, Saied Mirshahidi, Ph.D., Chong-Lei Bi, B.S., Wee-Joo Chng, MRCP, MRCPath, Heng-Wei Hsu, B.S., Shui-yan Wu, Jian Pan, Jian-nong Cen, Chien-Shing Chen, MD, PhD

Blood (2011) 118 (21): 1435.

https://doi.org/10.1182/blood.V118.21.1435.1435

Published: 2011

Journal Articles

Immune Mobilization with Direct In-Vivo Effector Response: Clinical Trial with Favorable Implications for Post-Transplant Outcome.

John M. Hill, MD, Jia-Yan Wu, PhD, Susan M. Webber, Lynn D. Root, Elizabeth A. Kimtis, Idalina C. Williams, Marc S. Ernstoff, MD, Zbigniew M. Szczepiorkowski, MD, Charles L. Sentman, PhD, Kenneth R. Meehan, MD

Blood (2007) 110 (11): 5120.

https://doi.org/10.1182/blood.V110.11.5120.5120

Published: 2007

Journal Articles

Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes

Dong-Ming Kuang, Yan Wu, Nini Chen, Jiasen Cheng, Shi-Mei Zhuang, Limin Zheng

Blood (2007) 110 (2): 587–595.

https://doi.org/10.1182/blood-2007-01-068031

Published: 2007

Includes: Supplemental data

Journal Articles

Large Scale Expansion of Activated T Cells: Defining Procedures and Cryopreservation Methods for Clinical Use as Adoptive Cellular Therapy Post-Transplant.

Jia-Yan Wu, PhD, Susan M. Webber, BS MT(ASAP) BB, John M. Hill, MD, Marc Ernstoff, MD, Zbigniew Szczepiorkowski, MD, PhD, Kenneth R. Meehan, MD

Blood (2006) 108 (11): 5232.

https://doi.org/10.1182/blood.V108.11.5232.5232

Published: 2006

Journal Articles

A Putative Role for VEGFR-1 (FLT-1) in B Cell Commitment and Differentiation.

Rita Fragoso, Catia Igreja, Claudia Appleton, Alexandra Henriques, Nuno Clode, Yan Wu, Zhenping Zhu, Sergio Dias, PhD

Blood (2006) 108 (11): 1152.

https://doi.org/10.1182/blood.V108.11.1152.1152

Published: 2006

Journal Articles

Immune Mobilization of Autologous Peripheral Blood Progenitor Cells: IL-2 with GM-CSF and G-CSF Results in Effective Mobilization without Delay in Engraftment.

John M. Hill, MD, Jia-Yan Wu, PhD, Susan M. Webber, BS, MT(ASAP), BB, Ortal Sharlin, Melinda Kendall, David McGregor, MT(ASCP), Marc J. Ernstoff, MD, Zbigniew M. Szczepiorkowski, MD, PhD, Kenneth R. Meehan, MD

Blood (2006) 108 (11): 5152.

https://doi.org/10.1182/blood.V108.11.5152.5152

Published: 2006

Journal Articles

VEGFR-1 (FLT-1) activation modulates acute lymphoblastic leukemia localization and survival within the bone marrow, determining the onset of extramedullary disease

Rita Fragoso, Teresa Pereira, Yan Wu, Zhenping Zhu, José Cabeçadas, Sérgio Dias

Blood (2006) 107 (4): 1608–1616.

https://doi.org/10.1182/blood-2005-06-2530

Published: 2006

Journal Articles

Synergistic Effects of Bortezomib with Low Dose Melphalan Against Human AML Cells.

Marc Gautier, MD, Jeffrey A. Bubis, DO, Jia-Yan Wu, Ph.D, Kenneth R. Meehan, MD

Blood (2005) 106 (11): 4463.

https://doi.org/10.1182/blood.V106.11.4463.4463

Published: 2005

Journal Articles

The Critical Role of the NKG2D Receptor in CD8+CTL and CD8+CD56+ NKT Cell Cytotoxicity.

Jia-Yan Wu, Ph.D, John M. Hill, MD, Marc Ernstoff, MD, Kenneth R. Meehan

Blood (2004) 104 (11): 3164.

https://doi.org/10.1182/blood.V104.11.3164.3164

Published: 2004

NARROW

Venetoclax Combined with Daunorubicin and Cytarabine (2 + 6) in Acute Myeloid Leukemia: Updated Results of a Phase II Trial

A Prognostic Nomogram Survival Model for Newly Diagnosed Patients with AIDS-Related Diffuse Large B-Cell Lymphoma: A Multicenter Cohort Study in China

Treatment Pattern and Survival of Human Immunodeficiency Virus Infection-Related Lymphoma in China 2008-2021

Clinical Analysis of 22 Cases of HIV-Associated Hodgkin Lymphoma in China

First-in-Human Clinical Study of a Novel CD7-Targeted Chimeric Antigen Receptor (CAR)-T Cell Therapy for Refractory/Relapsed Mixed Phenotype Acute Leukemia (MPAL)

Successful 24-Hours Manufacture of Anti-CD19/CD22 Dual Chimeric Antigen Receptor (CAR) T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Mitochondrial carrier homolog 2 is necessary for AML survival

Mitochondrial Carrier Homolog 2 (MTCH2) Regulates the Differentiation of AML Cells By Controlling Pyruvate Entry into the Mitochondria, Nuclear Localization of Pyruvate Dehydrogenase Complex and H3 and H4 Histone Acetylation

The Mitochondrial Carrier Homolog 2 (MTCH2) Regulates the Differentiation of AML Cells By Influencing the Localization of Pyruvate Dehydrogenase Complex and H3 and H4 Histone Acetylation

High Transcription Levels Of S100A8 and S100A9 In Acute Myeloid Leukemia Are Predictors For Poor Overall Survival

IGFBP7 Gene Promoting Cell Proliferation in Acute Myeloid Leukemia Through Activation of AKT3 and CCND1

C3aR1 Contributed to Acute Myeloid Leukemia Acquired Resistance to ABT-737 and Involved In the Process of AML

Immune Mobilization with Direct In-Vivo Effector Response: Clinical Trial with Favorable Implications for Post-Transplant Outcome.

Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes

Large Scale Expansion of Activated T Cells: Defining Procedures and Cryopreservation Methods for Clinical Use as Adoptive Cellular Therapy Post-Transplant.

A Putative Role for VEGFR-1 (FLT-1) in B Cell Commitment and Differentiation.

Immune Mobilization of Autologous Peripheral Blood Progenitor Cells: IL-2 with GM-CSF and G-CSF Results in Effective Mobilization without Delay in Engraftment.

VEGFR-1 (FLT-1) activation modulates acute lymphoblastic leukemia localization and survival within the bone marrow, determining the onset of extramedullary disease

Synergistic Effects of Bortezomib with Low Dose Melphalan Against Human AML Cells.

The Critical Role of the NKG2D Receptor in CD8+CTL and CD8+CD56+ NKT Cell Cytotoxicity.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only